Montelukast-Induced Urticaria;Acute Ischemic Colitis Caused by Anaphylactic Reaction;Pulmonary Edema Associated with a COX-2 Inhibitor;Hepatotoxicity with Citalopram;CNS Disturbances with Alendronate;Long QT Syndrome and QT Prolongation with Famotidine;Two Recommended Reviews
Restricted accessOtherFirst published online August, 2004
Montelukast-Induced Urticaria;Acute Ischemic Colitis Caused by Anaphylactic Reaction;Pulmonary Edema Associated with a COX-2 Inhibitor;Hepatotoxicity with Citalopram;CNS Disturbances with Alendronate;Long QT Syndrome and QT Prolongation with Famotidine;Two Recommended Reviews
The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), to discuss methods of prevention, and to promote reporting of ADRs to the FDA's MEDWATCH program (800-FDA-1088). If you have reported an interesting preventable ADR to MEDWATCH, please consider sharing the account with our readers.
In 2004, ISMP is celebrating the 10th anniversary of its incorporation as a nonprofit organization. The Institute represents more than 20 years of experience in helping health care practitioners keep patients safe, and continues to lead efforts to improve the medication use process.
Get full access to this article
View all access options for this article.
References
1.
Pérez-CarralC., CarreiraJ., VidalC.Acute ischaemic colitis due to hypotension and amoxicillin allergy. Postgrad Med J.2004; 80: 298–9.
2.
MinciulloP.L., SaijaA., BonannoD.Montelukast-induced generalized urticaria. Ann Pharmacother.2004; 38: 999–1001.
3.
OlinJ.L., ChanA., LazarusD.S.Pulmonary edema and possible pneumonitis associated with celecoxib [letter]. Ann Pharmacother.2004; 38: 1086
4.
LÛpez-TorresE., LucenaM.I., SeoaneJ.Hepatotoxicity related to citalopram [letter]. Am J Psychiatry.2004; 161: 923–4.